Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO System BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Big news in the peptide world. , The FDA has scheduled a formal hearing in July to review 7 peptides including BPC 157 and TB 500 for legal compounding. , This isnt approval. But its Everything You Need to Know About the FDA Peptide Ban Breaking News: FDA Unbans 14 Peptides for Legal US Compounding : r PeterAttia FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps